Neurocrine
Scientific Director, Bioconjugation Development
US CA San Diego · Director
Sponsorship not specified$186k-$253kDetected 14 days ago
FDA RegulatoryLeadershipCommunicationCollaboration
About the role
- By guiding functional development and aligning bioconjugation strategy with business priorities, you will have broad impact on both current programs and future platform development. _
- Your Contributions (include, but are not limited to):
- Establish long-term scientific vision for ADC, APC, AOC, and emerging bioconjugate modalities, influencing enterprise strategy
Responsibilities
- Lead design and execution of departmental strategies and policies for bioconjugate process development
- Maintain strategic oversight of functional deliverables
- Drive cross-functional initiatives with department-wide impact across discovery, manufacturing, quality, and regulatory functions
- Develop and oversee enterprise-level risk management strategies for bioconjugate products, platforms, and manufacturing processes
- Manage external manufacturing partnerships strategically
- Develop functional capabilities and leadership talent in bioconjugation development
- Lead teams driving strategic bioconjugation development initiatives across the portfolio
- Lead innovation initiatives across bioconjugation technologies, linker chemistries, payloads, and targeted delivery platforms
- Perform other duties as assigned
Requirements
- BS/BA in chemistry, biochemistry, biology, or similar scientific discipline and 12+ years of relevant experience OR
- MS/MA in chemistry, biochemistry, biology, or similar scientific discipline and 10+ years of relevant experience OR
- PhD in chemistry, biochemistry, biology, or similar scientific discipline or equivalent and 8+ years of relevant experience
- Extensive experience with bioconjugate manufacturing, technology transfer, and commercialization
Compensation
- The annual base salary we reasonably expect to pay is $185,600.00-$253,000.00.
Company info
- Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
- About the Role:
- Set the long-term scientific vision for bioconjugation development, shaping portfolio strategy for next-generation antibody-drug conjugates (ADCs), antibody-peptide conjugates (APCs), antibody-oligonucleotide conjugates (AOCs), and related targeted delivery platforms. This leadership role drives innovation in conjugation technologies, linker-payload design, manufacturability, and product development, while strengthening external scientific engagement and ensuring deep product understanding, CMC excellence, and regulatory credibility remain central to organizational decision-making. By guiding functional development and aligning bioconjugation strategy with business priorities, you will have broad impact on both current programs and future platform development. _
- Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs.
- We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders.
- The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.
- For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions.
- We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
- For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
- to relieve suffering for people with great needs.
Apply directly at Neurocrine →Create a free account for alerts like thisView Neurocrine immigration profile
This listing is sourced directly from Neurocrine's careers page and normalized into a canonical job model.